SCHEMBL20849574

SCHEMBL20849574

Cc1cc(C)cc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc2-c2c(C#N)cccc2-n2c3ccccc3c3cc(-c4cc(C)cc(C)c4)ccc32)c1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AR P10275 4/20 0.35
TACR1 P25103 1/20 0.31
ICMT O60725 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20849220 0.96 AR (0.38) ARTACR1ICMT
SCHEMBL20848531 0.96 AR (0.41) ARTACR1ICMT
SCHEMBL20849575 0.95 AR (0.32) AR
SCHEMBL20848536 0.95 AR (0.37) ARTACR1ICMT
SCHEMBL20849274 0.94 ICMT (0.32) ARTACR1ICMT
SCHEMBL20849308 0.94 AR (0.37) AR
SCHEMBL21399454 0.94 AR (0.36) ARICMT
SCHEMBL20849205 0.94 AR (0.36) ARTACR1
SCHEMBL20848535 0.92 AR (0.44) ARICMT
SCHEMBL20849296 0.92 TACR1 (0.33) TACR1ICMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10978646-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2021-04-13 US disclosed
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10978646-B2 Organic molecules for use in optoelectronic devices OCIAD2, OCIAD1, POU2F1 AR 3706/4885TACR1 2846/4885ICMT 616/4885
US-20190097141-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OCIAD2, OCIAD1, POU2F1 AR 3706/4885TACR1 2846/4885ICMT 616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.